POLARx Post Approval Study (POLARx PAS) | MicrobiomeTrials← Back to trialsNCT06170606
POLARx Post Approval Study (POLARx PAS)
CompletedNAINTERVENTIONAL
Trial Details
Start: 2024-06-28Est. Completion: 2026-05-20
Enrollment target: 200 participants Locations- Mercy Gilbert Medical Center, Gilbert, Arizona, United States
- Banner University Medical Center Phoenix, Phoenix, Arizona, United States
- Pima Heart & Vascular Clinical Research, Tucson, Arizona, United States
- Torrance Memorial Medical Center, Torrance, California, United States
- Intermountain Platte Valley Hospital, Brighton, Colorado, United States
- Valley View Hospital, Glenwood Springs, Colorado, United States
- St. Joseph's Hospital/BayCare Medical Group, Tampa, Florida, United States
- Bethesda North Hospital, Cincinnati, Ohio, United States
- Prisma Health Richland Hospital, Columbia, South Carolina, United States
- University of Texas Medical Branch - Galveston, Galveston, Texas, United States
- Aurora Health, Grafton, Wisconsin, United States
Other microbiome trials you might be interested in
Paroxysmal Atrial Fibrillation (PAF)Persistent Atrial Fibrillation
The goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely a…
Jonesboro, United StatesEst. completion Jul 20, 2028
Atrial FibrillationPersistent Atrial FibrillationParoxysmal AF
The objective of this feasibility study is to evaluate the safety and effectiveness of the FARAFLEX mapping and pulsed f…
Brussels, BelgiumEst. completion Feb 15, 2027